Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06606210 · ClinicalTrials.gov registry record · NA

INNOVEN: Efficacy of Porcine Placental Extracellular Matrix Plus Standard of Care (SOC) Versus SOC Alone

A NA study of Venous Leg Ulcer and Wound Heal, sponsored by ConvaTec.

Recruiting
Registry status
NA
Development phase
120
Enrollment target
1
Study location

NCT06606210 is a NA study of Venous Leg Ulcer and Wound Heal that is actively recruiting participants, run by ConvaTec. The registered enrollment target is 120 participants, below the 242-participant average among 35 other Venous Leg Ulcer trials with a reported enrollment target (50% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06606210, a NA study of Venous Leg Ulcer and Wound Heal, is actively recruiting participants, sponsored by ConvaTec.

RECRUITING
Registry status
NA
Development phase
120 participants
Enrollment target
1
Study location

Study Summary

INNOVEN is a multi-center randomized controlled clinical trial to evaluate the efficacy of porcine placental extracellular matrix (PPECM) and standard of care (SOC) versus SOC alone in the closure of non-healing venous leg ulcers (VLUs).

Interventions

  • DEVICE InnovaMatrix® AC

Study Locations (1)

Florida

  • Three Rivers Wound and Hyperbaric Center - North Port

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2024-09-19
Est. Completion 2026-04
Phase NA

Sponsor

ConvaTec

17 total trials

What the Registry Record Tells You About NCT06606210

The ClinicalTrials.gov registry entry for NCT06606210 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 242-participant average among 35 other Venous Leg Ulcer trials with a reported enrollment target (50% lower). The listed sponsor is ConvaTec, which has 17 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Venous Leg Ulcer appearing as the primary indexed condition, and to 1 intervention - of which InnovaMatrix® AC is the first listed.

NCT06606210 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT06606210 about?

NCT06606210 is a clinical study titled "INNOVEN: Efficacy of Porcine Placental Extracellular Matrix Plus Standard of Care (SOC) Versus SOC Alone". INNOVEN is a multi-center randomized controlled clinical trial to evaluate the efficacy of porcine placental extracellular matrix (PPECM) and standard of care (SOC) versus SOC alone in the closure of non-healing venous leg ulcers (VLUs).

What is the current status of trial NCT06606210?

This trial is currently recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2024-09-19. Estimated completion is 2026-04.

What conditions does trial NCT06606210 study?

This clinical trial studies the following conditions: Venous Leg Ulcer, Wound Heal.

What interventions are being tested in trial NCT06606210?

The interventions under investigation include: InnovaMatrix® AC (DEVICE).

Who is sponsoring clinical trial NCT06606210?

This trial is sponsored by ConvaTec, which has 17 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06606210 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Venous Leg Ulcer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.